|
Market Closed -
Nasdaq
06:00:00 28/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 89.29 USD | +0.37% |
|
-1.03% | +34.53% |
| 25/08 | Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing | MT |
| 13/08 | Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 94.12 | +5.41% | 25 | ||||||
| 120.2 | +7.72% | 25 | ||||||
| 98.44 | +9.41% | 25 | ||||||
| 369.31 | +14.97% | 13 | ||||||
| 30,666.67 | +25.35% | 15 | ||||||
| 194.42 | +3.34% | 12 | ||||||
| 44.62 | +28.76% | 26 | ||||||
| 404.73 | +16.94% | 15 | ||||||
| 3,133.08 | +22.39% | 13 | ||||||
| 263.12 | +12.94% | 8 | ||||||
| 232.64 | +18.27% | 14 | ||||||
| 107.57 | +8.13% | 21 | ||||||
| 93.92 | +3.29% | 13 | ||||||
| 42.95 | -2.84% | 11 | ||||||
| 28.73 | +10.79% | 11 | ||||||
| 208.6 | +31.33% | 15 | ||||||
| 103.23 | +25.07% | 13 | ||||||
| 329 | -15.63% | 5 | ||||||
| 185.7 | +2.02% | 20 | ||||||
| 171.91 | +19.87% | 22 | ||||||
| Average | 1,844.65 | +12.38% | 16 | ||||||
| Weighted average by Cap. | 2,357.29 | +11.62% | 19 |
- Stock Market
- Stocks
- DXCM Stock
- Sector DexCom, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
